PDS Biotechnology Corporation (PDSB) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.37B | -3.7M | -5.92M | -9.1M | -9.03M | -8.23M | -8M | -8.86M | -9.94M | -8.46M | -7.18M | -4.81M | -13.19M | -7.53M | -5.89M | -5.92M | -6.37M | -4.5M | -5.13M | 946.23K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -48300.38% | 55.04% | 26.05% | -2.75% | 9.12% | 2.63% | -11.48% | -83.99% | 24.65% | -12.33% | -21.77% | 18.66% | -107.08% | -67.26% | -14.9% | -725.52% | -67.51% | 2.76% | -309.62% | 123.06% |
| Net Income | -7.35M | 18.82B | -9.01M | -9.43M | -8.49M | -7.95M | -10.73M | -8.33M | -10.6M | -10.9M | -10.85M | -11.53M | -9.66M | -19.14M | -7.42M | -5.82M | -8.47M | -6.32M | -6.96M | -588.93K |
| Depreciation & Amortization | 0 | -1.18B | 5.46K | 15.13K | 5.46K | 5.46K | 5.46K | 298.9K | 4.74K | 4.74K | 4.73K | 4.74K | 3.15K | 0 | 97.67K | 60.26K | 60.34K | 61.21K | 61.53K | 1.27K |
| Stock-Based Compensation | 0 | -1.79B | 1.25M | 0 | 1.25M | 1.64M | 1.78M | 1.8M | 1.63M | 1.35M | 2.07M | 2.11M | 2.08M | 1.37M | 0 | 0 | 0 | 0 | 0 | 441.6K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4.37B | -15.85B | 455.33K | 1.56M | 485.75K | 307.44K | 314.8K | -2.48M | 279.91K | 680.76K | 208.24K | 791.45K | 193.21K | 5.18M | 1.42M | 1.35M | 1.13M | 1.67M | 1.7M | 60.26K |
| Working Capital Changes | 1.36M | 1.76M | 1.39M | -1.24M | -2.29M | -2.24M | 628.44K | -143.29K | -1.25M | 400.69K | 1.39M | 3.82M | -5.81M | 5.05M | 16.8K | -1.51M | 915.2K | 83.88K | 68.97K | 1.03M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 75.9K | -1.61M | 683.49K | 1.64M | 1.17M | 383.95K | -1.95M | 0 | -981.99K | 1.62M | 951.66K | 2.34M | 852.77K | -818.1K | 159.4K | -867.72K | 1.44M | -136.18K | -929.78K | 1.42M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -679.83M | 4.22M | 241.21K | 995.94K | 7.32M | 172.78K | 17.22K | -13.79K | 20.01M | 10.77M | 802.33K | 240.01K | 4.57M | 9.71M | 24.55M | 22.43K | 7.49K | 13 | 123.51K | 48.77M |
| Debt Issued (Net) | -1.51M | -2.94M | -1.02M | -19.7M | -3.14M | -3.14M | -14.11K | -13.79K | -13.47K | -13.17K | -12.88K | -12.59K | -20.67K | 0 | 24.55M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 833.37K | 7.16M | 1.26M | 20.7M | 7.3M | 3.17M | -67.18K | 0 | 19.49M | 10.48M | 815.2K | 243.74K | 4.59M | 9.86M | 0 | 22.43K | 7.49K | 13 | 123.51K | 48.54M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -679.15M | 0 | 0 | 0 | 3.16M | 144.5K | 98.5K | 0 | 531.09K | 300.09K | 0 | 8.85K | 0 | -149.46K | 0 | 0 | 0 | 0 | 0 | 220.6K |
| Net Change in Cash | -5.05B | 513.32K | -5.67M | -8.11M | -1.71M | -8.06M | -7.98M | -8.9M | 10.07M | 2.31M | -6.37M | -4.57M | -8.62M | 2.18M | 18.66M | -5.9M | -6.36M | -4.5M | -5.01M | 49.71M |
| Free Cash Flow | -4.37B | -3.7M | -5.92M | -9.1M | -9.03M | -8.23M | -8M | -8.89M | -9.94M | -8.46M | -7.18M | -4.81M | -13.19M | -7.53M | -5.89M | -5.92M | -6.37M | -4.5M | -5.13M | 946.23K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -48300.38% | 55.04% | 26.05% | -2.41% | 9.12% | 2.63% | -11.48% | -84.59% | 24.65% | -12.33% | -21.77% | 18.66% | -107.08% | -67.26% | -14.9% | -725.52% | -67.51% | 2.76% | -309.62% | 123.06% |
| FCF per Share | -78.77 | -0.08 | -0.13 | -0.20 | -0.22 | -0.23 | -0.22 | -0.24 | -0.29 | -0.27 | -0.23 | -0.16 | -0.43 | -0.26 | -0.21 | -0.21 | -0.24 | -0.16 | -0.18 | 0.04 |
| FCF Conversion (FCF/Net Income) | 594.86x | 0.49x | 0.66x | 0.96x | 1.06x | 1.04x | 0.75x | 1.06x | 0.94x | 0.78x | 0.66x | 0.42x | 1.37x | 0.39x | 0.79x | 1.02x | 0.75x | 0.71x | 0.74x | -1.61x |
| Interest Paid | 0 | 0 | 702.71K | 0 | 693.99K | 835.31K | 358.64K | 1.19M | 1.17M | 503.94K | 662.41K | 995.4K | 966.85K | 789.72K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |